Stock Events

Stock Events

Brainstorm Cell Therapeutics (BCLI) Q2 2026 Earnings

15MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.97

-0.71

-0.45

-0.19

Details

Expected EPS

-0.36

Actual EPS

-0.19

Surprise EPS

0.17

Surprise Percent

+47.22%

Description

Brainstorm Cell Therapeutics (BCLI) has reported earnings of -0.19 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.